13 December 2018 3 Min Read
STEPHEN CRANSTON: When defensive shares are anything but
One of the worst-performing large caps was Mediclinic, which was down 37%, much worse than the 12.4% of the Capped Swix benchmark
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In